Related Experiment Video
Updated: Jun 16, 2026

06:24
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.0K
Enhancement Strategy for Protocatechuic Acid Production Using Corynebacterium glutamicum with Focus on Continuous
Jiwoon Chung1,2, Wooshik Shin3, Chulhwan Park1
1Department of Chemical Engineering, Kwangwoon University, 20, Gwangun-ro, Nowon-gu, Seoul 01897, Republic of Korea.
International Journal of Molecular Sciences
|January 11, 2025
Summary
Microbial production of protocatechuic acid (PCA) was enhanced using Corynebacterium glutamicum. Optimized fermentation achieved over 5 g/L PCA, overcoming cytotoxicity for industrial applications.
Area of Science:
- Biotechnology
- Metabolic Engineering
- Industrial Microbiology
Background:
- Protocatechuic acid (PCA) is a valuable phenolic acid with diverse biological functions.
- Microbial synthesis offers a sustainable and efficient alternative to plant extraction for PCA production.
- High yields and energy savings are key advantages of microbial PCA synthesis.
Purpose of the Study:
- To optimize the production medium for enhanced PCA yield in Corynebacterium glutamicum.
- To investigate and mitigate PCA cytotoxicity during fermentation.
- To establish a continuous fermentation process for sustained PCA production.
Main Methods:
- Statistical optimization including full factorial design, steepest ascent, and response surface methodology.
- Batch and continuous fermentation strategies were employed.
- Cytotoxicity analysis of PCA on C. glutamicum growth and production.
Main Results:
- Optimized medium significantly increased PCA production to over 5 g/L in 72 h batch culture.
- PCA demonstrated cytotoxicity at approximately 5 g/L, inhibiting strain growth.
- Continuous fermentation sustained PCA production for 150 h by maintaining sub-inhibitory concentrations.
Conclusions:
- Statistical optimization effectively enhanced PCA production in C. glutamicum.
- Managing PCA cytotoxicity is crucial for high-yield microbial production.
- The developed methods pave the way for industrial-scale PCA manufacturing.
Keywords:
Corynebacterium glutamicumcontinuous cultivationcytotoxicity managementprotocatechuateprotocatechuic acidstatistical medium optimizationMore Related Videos
Related Concept Videos
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

